Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
14245 | 782 | 28.0 | 52% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
6 | 4 | GASTROENTEROLOGY & HEPATOLOGY//ONCOLOGY//SURGERY | 1371034 |
216 | 3 | NON SMALL CELL LUNG CANCER//LUNG CANCER//THORAC SURG | 51214 |
1102 | 2 | PACLITAXEL//TAXANES//EPOTHILONES | 9807 |
14245 | 1 | VINFLUNINE//VINCA ALKALOIDS//VINCRISTINE | 782 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | VINFLUNINE | authKW | 1162054 | 6% | 60% | 50 |
2 | VINCA ALKALOIDS | authKW | 242620 | 4% | 18% | 34 |
3 | VINCRISTINE | authKW | 236794 | 10% | 8% | 75 |
4 | INTRATHECAL VINCRISTINE | authKW | 195232 | 1% | 100% | 5 |
5 | CATHARANTHUS ALKALOIDS | authKW | 117139 | 0% | 100% | 3 |
6 | VINORELBINE | authKW | 99642 | 6% | 5% | 49 |
7 | ONCOL PHARMACOKINET | address | 89245 | 1% | 57% | 4 |
8 | 4 O DEACETYLVINFLUNINE | authKW | 78093 | 0% | 100% | 2 |
9 | 4 O DEACETYLVINORELBINE | authKW | 78093 | 0% | 100% | 2 |
10 | ASCENDING MYELOENCEPHALOPATHY | authKW | 78093 | 0% | 100% | 2 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 8856 | 55% | 0% | 428 |
2 | Pharmacology & Pharmacy | 2223 | 32% | 0% | 252 |
3 | CYTOLOGY & HISTOLOGY | 607 | 1% | 0% | 11 |
4 | Chemistry, Analytical | 260 | 9% | 0% | 72 |
5 | Hematology | 90 | 4% | 0% | 32 |
6 | Pediatrics | 85 | 5% | 0% | 36 |
7 | Biochemical Research Methods | 53 | 4% | 0% | 29 |
8 | Chemistry, Medicinal | 36 | 3% | 0% | 22 |
9 | Toxicology | 31 | 3% | 0% | 21 |
10 | Medicine, Legal | 11 | 1% | 0% | 4 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ONCOL PHARMACOKINET | 89245 | 1% | 57% | 4 |
2 | EXPT CANC 1 | 78093 | 0% | 100% | 2 |
3 | QUAL CONTROL ANALYT | 78093 | 0% | 100% | 2 |
4 | MED CHEM 5 | 70281 | 0% | 60% | 3 |
5 | I DEV SPECT | 52060 | 0% | 67% | 2 |
6 | ADULT LEUKEMIA UNIT | 39046 | 0% | 100% | 1 |
7 | ALTERNAT METABOL THER EUT EXPT | 39046 | 0% | 100% | 1 |
8 | AREA HISTOL HUMANA ANAT PATOL | 39046 | 0% | 100% | 1 |
9 | CHILDRENS HOSP COLORADO CANC BLOOD DISORDER | 39046 | 0% | 100% | 1 |
10 | CHUACA CORUNA | 39046 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CANCER CHEMOTHERAPY AND PHARMACOLOGY | 28352 | 9% | 1% | 73 |
2 | CANCER TREATMENT REPORTS | 20450 | 4% | 2% | 34 |
3 | CELL AND TISSUE KINETICS | 6644 | 1% | 2% | 10 |
4 | INVESTIGATIONAL NEW DRUGS | 5497 | 2% | 1% | 19 |
5 | CANCER TREATMENT REVIEWS | 3919 | 2% | 1% | 14 |
6 | BULLETIN DU CANCER | 2352 | 2% | 0% | 16 |
7 | MEDICAL AND PEDIATRIC ONCOLOGY | 2231 | 2% | 0% | 12 |
8 | JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS | 2114 | 2% | 0% | 14 |
9 | AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 1376 | 2% | 0% | 12 |
10 | CANCER DRUG DELIVERY | 1342 | 0% | 2% | 2 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | VINFLUNINE | 1162054 | 6% | 60% | 50 | Search VINFLUNINE | Search VINFLUNINE |
2 | VINCA ALKALOIDS | 242620 | 4% | 18% | 34 | Search VINCA+ALKALOIDS | Search VINCA+ALKALOIDS |
3 | VINCRISTINE | 236794 | 10% | 8% | 75 | Search VINCRISTINE | Search VINCRISTINE |
4 | INTRATHECAL VINCRISTINE | 195232 | 1% | 100% | 5 | Search INTRATHECAL+VINCRISTINE | Search INTRATHECAL+VINCRISTINE |
5 | CATHARANTHUS ALKALOIDS | 117139 | 0% | 100% | 3 | Search CATHARANTHUS+ALKALOIDS | Search CATHARANTHUS+ALKALOIDS |
6 | VINORELBINE | 99642 | 6% | 5% | 49 | Search VINORELBINE | Search VINORELBINE |
7 | 4 O DEACETYLVINFLUNINE | 78093 | 0% | 100% | 2 | Search 4+O+DEACETYLVINFLUNINE | Search 4+O+DEACETYLVINFLUNINE |
8 | 4 O DEACETYLVINORELBINE | 78093 | 0% | 100% | 2 | Search 4+O+DEACETYLVINORELBINE | Search 4+O+DEACETYLVINORELBINE |
9 | ASCENDING MYELOENCEPHALOPATHY | 78093 | 0% | 100% | 2 | Search ASCENDING+MYELOENCEPHALOPATHY | Search ASCENDING+MYELOENCEPHALOPATHY |
10 | CROSS RESISTANCE PROFILE | 78093 | 0% | 100% | 2 | Search CROSS+RESISTANCE+PROFILE | Search CROSS+RESISTANCE+PROFILE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | VANTELLINGEN, O , SIPS, JHM , BEIJNEN, JH , BULT, A , NOOIJEN, WJ , (1992) PHARMACOLOGY, BIOANALYSIS AND PHARMACOKINETICS OF THE VINCA ALKALOIDS AND SEMISYNTHETIC DERIVATIVES (REVIEW).ANTICANCER RESEARCH. VOL. 12. ISSUE 5. P. 1699-1715 | 64 | 70% | 41 |
2 | BENNOUNA, J , DELORD, JP , CAMPONE, M , NGUYEN, L , (2008) VINFLUNINE: A NEW MICROTUBULE INHIBITOR AGENT.CLINICAL CANCER RESEARCH. VOL. 14. ISSUE 6. P. 1625-1632 | 27 | 93% | 38 |
3 | SAID, R , TSIMBERIDOU, AM , (2014) PHARMACOKINETIC EVALUATION OF VINCRISTINE FOR THE TREATMENT OF LYMPHOID MALIGNANCIES.EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY. VOL. 10. ISSUE 3. P. 483 -494 | 41 | 44% | 4 |
4 | PUOZZO, C , UNG, HL , ZORZA, G , (2007) A HIGH PERFORMANCE LIQUID CHROMATOGRAPHY METHOD FOR VINORELBINE AND 4-O-DEACETYL VINORELBINE: A DECADE OF ROUTINE ANALYSIS IN HUMAN BLOOD.JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS. VOL. 44. ISSUE 1. P. 144-149 | 23 | 92% | 14 |
5 | LEVEQUE, D , WIHLM, J , JEHL, F , (1996) PHARMACOLOGY OF CATHARANTHUS ALKALOIDS..BULLETIN DU CANCER. VOL. 83. ISSUE 3. P. 176-186 | 45 | 63% | 28 |
6 | GILBAR, PJ , DOOLEY, MJ , (2007) REVIEW OF CASE REPORTS OF INADVERTENT INTRATHECAL ADMINISTRATION OF VINCRISTINE: RECOMMENDATIONS TO REDUCE OCCURRENCE.ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY. VOL. 3. ISSUE 2. P. 59-65 | 22 | 92% | 8 |
7 | DAMENA, CWN , ROSING, H , TIBBEN, MM , VAN MAANEN, MJ , LAGAS, JS , SCHINKEL, AH , SCHELLENS, JHM , BEIJNENA, JH , (2008) A SENSITIVE ASSAY FOR THE QUANTITATIVE ANALYSIS OF VINORELBINE IN MOUSE AND HUMAN EDTA PLASMA BY HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY COUPLED WITH ELECTROSPRAY TANDEM MASS SPECTROMETRY.JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES. VOL. 868. ISSUE 1-2. P. 102-109 | 25 | 76% | 8 |
8 | LEVEQUE, D , JEHL, F , (1996) CLINICAL PHARMACOKINETICS OF VINORELBINE.CLINICAL PHARMACOKINETICS. VOL. 31. ISSUE 3. P. 184-197 | 41 | 61% | 53 |
9 | GILBAR, PJ , (2014) INTRATHECAL CHEMOTHERAPY POTENTIAL FOR MEDICATION ERROR.CANCER NURSING. VOL. 37. ISSUE 4. P. 299 -309 | 30 | 53% | 2 |
10 | REDDY, GK , BROWN, B , NANDA, A , (2011) FATAL CONSEQUENCES OF A SIMPLE MISTAKE: HOW CAN A PATIENT BE SAVED FROM INADVERTENT INTRATHECAL VINCRISTINE?.CLINICAL NEUROLOGY AND NEUROSURGERY. VOL. 113. ISSUE 1. P. 68-71 | 16 | 100% | 12 |
Classes with closest relation at Level 1 |